The American Society for Biochemistry and Molecular Biology

Driving fundamental discoveries and supporting scientists at all stages of their careers.

Science serves us all
Ask your elected officials to protect fundamental science — our toolkit makes it easy!
Two students examine a model molecule at an ASBMB Annual Meeting poster session
Federal funding supports research that drives innovation, improves public health and fuels the U.S. economy.
Two students examine a model molecule at an ASBMB Annual Meeting poster session
Programs that support evidence-based teaching and inclusive pedagogy empower educators and the next generation of scientists.
Hear about the latest science featured in ASBMB’s journals.

ASBMB journals

The ASBMB's three prestigious journals offer a platform for your research with the benefit of editorial feedback, fast turnaround and open access.

thumbnail

Journal of Biological Chemistry

JBC publishes high-quality science that seeks to elucidate the molecular and cellular basis of biological processes.

thumbnail

Molecular & Cellular Proteomics

MCP showcases cutting-edge advances in proteomics, metabolomics and bioinformatics.

thumbnail

Journal of Lipid Research

JLR is the most cited journal devoted to lipids in the world, focusing on the science of lipids in health and disease.

ASBMB Today
ASBMB committees welcome new members

ASBMB committees welcome new members

By ASBMB Staff

Members joined these committees: Education and Professional Development, Maximizing Access, Meetings, Membership, Public Affairs Advisory, Science Outreach and Communication, Student Chapters and Women in Biochemistry and Molecular Biology.

More from ASBMB Today
Upcoming opportunities

Register for the free ASBMB Breakthroughs webinar on chemical approaches to sorting out histone modifications, happening on Aug. 13!

Receptor antagonist reduces age-related bone loss in mice

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.

Pathogen-derived enzyme engineered for antibiotic design

Engineered variants of a bacterial enzyme developed at the University at Buffalo accept larger substrates, paving the way for new acinetobactin-based antimicrobials. Read more about this recent JBC paper.